This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Senior Vice President and Chief Financial Officer (CFO)
Judy Huber brings to BrainsWay more than 25 years of financial experience, predominately in the medical device industry. Most recently, Judy served as Chief Financial Officer (CFO) of NinePoint Medical, a privately-held medical device company that designed, manufactured, and sold an Optical Coherence Tomography (OCT) imaging platform for clinical use in gastroenterology. Prior to joining NinePoint, Judy served as CFO of ConforMIS, Inc. (Nasdaq: CFMS), where she was an integral member of the leadership team that created the foundation for the operational and commercial strategy of the company’s patient-specific knee replacement systems. Before ConforMIS, she served as Vice President and Controller at NxStage Medical (NYSE: FMS). In this role, she was instrumental in building the financial and administrative infrastructure that led to the company’s initial public offering, secondary financing, and acquisition of Medisystems Corporation.
Earlier in her career, Judy spent more than nine years in various financial positions with a billion dollar plus medical device company, C.R. Bard (now part of Becton Dickinson, NYSE: BDX), where she supported multiple divisions focused on improving the economic efficiencies in their manufacturing operations. Judy holds a Master of Business Administration degree from Babson College (Wellesley, MA), and a Bachelor of Science degree in Accounting from the State University of New York at Geneseo (Geneseo, NY).